Anticancer and bioactivity effect of the AraA-IL13 fusion protein on the glioblastoma cell line

Background and purpose: Glioblastoma (GBM) is an aggressive and malignant brain cancer with the highest mortality and low survival rates. To discover a more specific and efficient treatment for GBM, we synthesized and examined the cytotoxic effect of arazyme-interleukin-13 (Ara-IL13) fusion protein...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Rezvan Mehrab (Autor), Hamid Sedighian (Autor), Fattah Sotoodehnejadnematalahi (Autor), Raheleh Halabian (Autor), Abbas Ali Imanifooladi (Autor)
Format: Knjiga
Izdano: Wolters Kluwer Medknow Publications, 2024-08-01T00:00:00Z.
Teme:
Online pristup:Connect to this object online.
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Internet

Connect to this object online.

3rd Floor Main Library

Detalji primjeraka od 3rd Floor Main Library
Signatura: A1234.567
Primjerak 1 Dostupno